The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by
Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Coca-Cola Europacific Partners (CCEP – Research Report) and Monster Beverage (MNST – Research Report).
Coca-Cola Europacific Partners (CCEP)
In a report released today, Bonnie Herzog from Goldman Sachs reiterated a Buy rating on Coca-Cola Europacific Partners. The company’s shares closed last Wednesday at $69.66.
According to TipRanks.com, Herzog is a 4-star analyst with an average return of
Currently, the analyst consensus on Coca-Cola Europacific Partners is a Strong Buy with an average price target of $76.99, representing a 12.5% upside. In a report issued on April 12, Barclays also maintained a Buy rating on the stock with a $75.00 price target.
See the top stocks recommended by analysts >>
Monster Beverage (MNST)
Monster Beverage received a Sell rating and a $46.00 price target from Truist Financial analyst Bill Chappell today. The company’s shares closed last Wednesday at $54.33.
According to TipRanks.com, Chappell is a 4-star analyst with an average return of
Currently, the analyst consensus on Monster Beverage is a Moderate Buy with an average price target of $63.44.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CCEP:
As previously reported, Truist downgraded Monster Beverage to Sell from Buy with a price target of $46, down from $65. While the firm still views Monster as “a great company,”
Truist מכירים בכך ש-Monster היא “חברה נהדרת”, אך אינם מאמינים שהיא תמשיך לצמוח במהירות. הפירמה גם חושבת שוול סטריט אופטימית מדי לגבי יכולתה של החברה לשפר את שולי הרווח הגולמיים
Truist downgraded Monster Beverage to Sell from Buy with a price target of $46, down from $65. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial